ZB · 02Pair
Nocturne
Deep sleep architecture for nocturnal repair. Synergistic with Apex.
$112
Developed over two years in collaboration with sports medicine researchers. A stabilized BPC analog paired with a proprietary tripeptide carrier — engineered for tissue repair, gut integrity, and post-training recovery.
Apex pairs a stabilized BPC analog with a proprietary tripeptide carrier, creating a compound that crosses tissue barriers more efficiently than standard BPC-157 formulations in independent pharmacokinetic studies.
Lyophilized and sealed under nitrogen at our cGMP facility in Basel. Each 5mg vial represents approximately a 30-day research protocol at standard dosing.
Full chromatograms, HPLC data, and independent endotoxin results for Lot ZB-2604-A are available in the COA tab above.
Results from independent in-vitro studies. Not intended to represent clinical outcomes.
The following protocol is based on published research and designed for laboratory use only. Consult a qualified researcher before beginning any peptide protocol.
| Phase | Dose | Frequency | Duration | Notes |
|---|---|---|---|---|
| Loading | 400 mcg | Twice daily | Weeks 1–2 | AM and PM, away from meals |
| Maintenance | 250 mcg | Once daily | Weeks 3–4 | AM administration preferred |
| Cycle break | — | — | 2 weeks | Allow receptor clearance |
| Optional re-run | 250 mcg | Once daily | Up to 4 weeks | Reassess markers before repeating |
Add 1–2 mL bacteriostatic water to the lyophilized vial. Swirl gently — do not vortex. Store reconstituted peptide at 4°C and use within 30 days.
Subcutaneous injection is standard in published literature. Injection site rotation is recommended. Aspirate before injection. Discard if solution becomes cloudy.
Commonly paired with TB-500 (Accord ZB-06) for synergistic tissue repair. Separate injections by at least 6 hours. Avoid co-administration with NSAIDs during loading phase.
All five independent tests passed. Conducted by Eurofins Scientific, ISO 17025 accredited. Results published in full below.
Testing laboratory: Eurofins Scientific GmbH, Hamburg · ISO 17025 accredited · Report date: April 18, 2026
The following citations represent the published literature informing the design of Apex 01. All studies are independent, peer-reviewed, and publicly accessible via their listed DOI or PubMed identifier.
Not for human consumption. This product is sold exclusively for research and educational purposes. It is not intended to diagnose, treat, cure, or prevent any disease.
All clinical trial data and research findings presented on this page are sourced from peer-reviewed journals and official publications. They are provided for educational reference only and should not be interpreted as medical advice or product claims.
By purchasing this product, you confirm that you are a qualified researcher and will use it in accordance with all applicable laws and regulations.
Apex is most effective when paired with a complementary formulation. Research suggests combining recovery peptides with a sleep stack for optimal tissue repair outcomes.